NCT03411187

Brief Summary

Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 26, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

September 18, 2018

Status Verified

September 1, 2018

Enrollment Period

6 months

First QC Date

January 19, 2018

Last Update Submit

September 17, 2018

Conditions

Keywords

EndoscopyThyroidectomyThyroid Cancer

Outcome Measures

Primary Outcomes (3)

  • Flap separation time

    Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space.

    1 day after surgery

  • Glandular excision time

    Glandular excision time was defined from incising cervical white line to removing Berry ligament.

    1 day after surgery

  • Central lymph node dissection time

    Central lymph node dissection time: was from separating central lymph node to the specimen removed.

    1 day after surgery

Secondary Outcomes (6)

  • Times of wiping lens

    1 day after surgery

  • Volume of intraoperative blood loss

    1 day after surgery

  • Volume of Postoperative drainage

    1 day,2 day,3 day after surgery

  • The number of identifying parathyroid glands

    1 day after surgery

  • Blood PTH level

    preoperative, first day after operation, one week after surgery, two months after surgery.

  • +1 more secondary outcomes

Study Arms (2)

foot-control exhaust group

ACTIVE COMPARATOR

The foot-control exhaust group used of the Pressure adjustable foot-control method by the way of adjustable Pressure to intermittent exhaust

Device: used of the Pressure adjustable foot-control method

direct exhaust group

PLACEBO COMPARATOR

direct exhaust group exhaust through the Trocar hole.and without use of the Pressure adjustable foot-control method

Device: direct exhaust

Interventions

Whether The Pressure adjustable foot-control method is used.

foot-control exhaust group

direct exhaust through the trocar.

direct exhaust group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with maximum tumor diameter ≤1 cm;
  • patients without lateral neck lymph node metastases;
  • patients without distant metastases;
  • patients who only needed unilateral surgery following the guidelines;
  • patients with strong cosmetic requirement.

You may not qualify if:

  • Patients with maximum tumor diameter \>1 cm;
  • patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases;
  • patients without cosmetic requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wen-xin ZHAO

Fuzhou, Fujian, 350001, China

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid Cancer, Papillary

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesAdenocarcinoma, PapillaryAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Central Study Contacts

Wen-xin ZHAO, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a prospective randomized controlled study to select a continuous case of thyroid surgery in the fujian medical university union hospital from January 2017 to June 2017.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 19, 2018

First Posted

January 26, 2018

Study Start

January 1, 2018

Primary Completion

June 30, 2018

Study Completion

December 30, 2018

Last Updated

September 18, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations